Muna Therapeutics
Manufacturing · Denmark · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Ole Maaløes Vej 3, Copenhagen, Capital R...Phone Number
+45 28989056Website
www.munatherapeutics.comRevenue
$6.1 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About Muna Therapeutics
Muna Therapeutics discovers and develops therapies that slow or stop devastating neurodegenerative diseases including Alzheimer’s, Frontotemporal Dementia and Parkinson’s. These disorders impact memory, movement, language, behavior and personality resulting in disability and death of millions of patients around the globe.Explore more
Muna Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Muna Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Muna Therapeutics has new funding data
Check out if Muna Therapeutics is spiking on competitors!
Earning: See what the market has to say on Muna Therapeutics recently announced quarterly report
Product Launch: Get notified when Muna Therapeutics launches new products
Check if Muna Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Muna Therapeutics
Muna Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Muna Therapeutics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Muna Therapeutics
Find 2 more new buyers
Company Profile Activity
Activity Insights
Muna Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Muna Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Muna Therapeutics.
Muna Therapeutics financials insights
Gather financial insights about Muna Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Series A
$73M
Muna Therapeutics Tech Stack
A closer look at the technologies used by Muna Therapeutics
See more technologies
Most Recent Scoops
Person-Based
New Hire
Executive Move
Funding
Funding
Muna Therapeutics News & Media
Muna Therapeutics Awarded $1 Million Alzheimer's Association Grant to Advance Clinical Development of Novel Oral TREM2 Agonist MNA-001 for Alzheimer's
Funds to support ongoing Phase 1 trial of MNA-001 and validation of translational biomarkers for TREM2 function in Alzheimer's Work will inform Phase 2 trials assessing the potential of MNA-001 to slow pathology progression and functional decline Validates Muna's differentiated...Muna Therapeutics Announces First Subjects Dosed in Phase 1 Trial of Novel Oral TREM2 Agonist for Early Alzheimer's Disease
MNA-001 has best-in-class potential based on preclinical data demonstrating ability to significantly reduce neurotoxic amyloid burden and reprogram microglia to protective states Phase 1 study initiated to assess safety, tolerability, pharmacokinetics and pharmacodynamic effects of...Muna Therapeutics Announces Strategic Alliance with GSK to Accelerate Development of Novel Treatments for Alzheimer's Disease
Multi-year effort leverages Muna's all-in-human MiND-MAP spatial multi-omics approach to identify and validate new drug targets and treatment pathways for Alzheimer's disease GSK secures option to multiple high-value, validated Alzheimer's-relevant targets for drug discovery, development,...Muna Therapeutics Awarded $4.9M Grant from The Michael J. Fox Foundation for Parkinson's Research
Supports Development of Disease Modifying Therapy for Parkinson's Disease COPENHAGEN, Denmark and BOSTON, Oct. 11, 2022 /PRNewswire/ -- Muna Therapeutics (Muna), a biopharmaceutical company discovering and developing novel therapeutics for the treatment of Parkinson's disease and other...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Muna Therapeutics
Sign Up For FreeTo access detailed company insights
Muna Therapeutics discovers and develops therapies that slow or stop devastating neurodegenerative diseases including Alzheimer’s, Frontotemporal Dementia and Parkinson’s. These disorders impact memory, movement, language, behavior and personality resulting in disability and death of millions of patients around the globe.... Read More
